Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Michael Francis Walsh"'
Autor:
Tamara Lamprecht, B E Cauff, Gang Wu, Shuoguo Wang, Marcin W. Wlodarski, Jeffery M. Klco, Jason R. Schwartz, Rose B. McGee, Jing Ma, Guangchun Song, Susana C. Raimondi, Kim E. Nichols, Michael Francis Walsh, Chimene Kesserwan, Michael Walsh, Raul C. Ribeiro
Publikováno v:
Leukemia
Autor:
Karen Cadoo, Alicia Latham, Robert A. Soslow, Jaclyn F. Hechtman, Ozge Birsoy, Ying L Liu, Michael Francis Walsh, Sarah R. Kane, Diana Mandelker, Yelena Kemel, Erin E. Salo-Mullen, Maria I. Carlo, Jinru Shia, Arnold J. Markowitz, Megha Ranganathan, Anna Maio, Zsofia K. Stadler, Zalak Patel, Kenneth Offit, Amanda Catchings
Publikováno v:
Journal of Clinical Oncology. 39:10516-10516
10516 Background: Recently updated NCCN guidelines for management of germline MSH6 and PMS2 pathogenic/likely pathogenic (P/LP) variant carriers suggest a more modest phenotype with later onset colorectal cancer (CRC) and limited extra-colonic cancer
Autor:
Alicia Latham, Anna Maio, Margaret Sheehan, Ying L Liu, Carol Aghajanian, Maria I. Carlo, Luis A. Diaz, Kenneth Offit, Magan Trottier, Megan Harlan Fleischut, Jada G. Hamilton, Diana Mandelker, Carol L. Brown, Mark E. Robson, Prince Rainier Tejada, Yelena Kemel, Zsofia K. Stadler, Erin E. Salo-Mullen, Michael Francis Walsh
Publikováno v:
Journal of Clinical Oncology. 39:10508-10508
10508 Background: Disparities in access to germline testing for cancer patients (pts) have been demonstrated; however, disparities in post-testing care are unknown. We sought to evaluate germline findings and subsequent genetic counseling/care in can
Autor:
Julia Glade Bender, Emily K. Slotkin, Gunes Gundem, Emily Stockfisch, Ahmet Zehir, Andrew L. Kung, Agnes Viale, Nancy Bouvier, Neerav Shukla, Shakeel Modak, Barbara Spitzer, Juan E. Arango Ossa, Elli Papaemmanuil, Jesus Gutierrez-Abril, Filemon S. Dela Cruz, Max Levine, Michael Francis Walsh, Matthias A. Karajannis, Tara O'Donohue, Juan S. Medina-Martinez
Publikováno v:
Journal of Clinical Oncology. 39:3063-3063
3063 Background: Next generation sequencing (NGS) assays have accelerated the identification of mutations and potential matched targeted therapies for patients with cancer. However, a significant proportion of patients do not derive clinical benefit
Autor:
Judy Garber, Mark E. Robson, Vanessa Marcell, Michael Francis Walsh, Heather Symecko, Jada G. Hamilton, Susan M. Domchek, Fergus J. Couch, Jamie Brower, Kenneth Offit
Publikováno v:
Journal of Clinical Oncology. 38:1508-1508
1508 Background: With the expansion of multigene panel testing for cancer susceptibility, increasing numbers of patients are identified with pathogenic/likely pathogenic variants (P/LP V) in genes which do not have a clearly actionable increased risk
Autor:
Diana Mandelker, Ying L Liu, Kenneth Offit, Maria I. Carlo, Marianne E Dubard-Gault, Karen Cadoo, Michael F. Berger, Venkatraman E. Seshan, Kaitlyn Tkachuk, Vignesh Ravichandran, Yuhan Wang, Semanti Mukherjee, Erin E. Salo-Mullen, Alicia Latham, Michael Francis Walsh, Zsofia K. Stadler, Vijai Joseph, Mark E. Robson, Aliya Khurram, Yelena Kemel
Publikováno v:
Journal of Clinical Oncology. 38:1502-1502
1502 Background: 17% of patients (pts) with a cancer diagnosis in the U.S. have a prior malignancy. We sought to characterize pts with multiple (≥2) primary cancers (MPC) & identify potential drivers of cancer risk to guide management. Methods: Pts
Autor:
Yelena Kemel, Ozge Birsoy, Karen Cadoo, Audrey Mauguen, Neerav Shukla, Elise Fiala, Stephen S. Roberts, Andrew L. Kung, Mark E. Robson, Ahmet Zehir, Anna Maio, Maria I. Carlo, Alicia Latham, Zsofia K. Stadler, Kenneth Offit, Michael Francis Walsh, Jennifer Kennedy, Diana Mandelker, Nancy Bouvier
Publikováno v:
Journal of Clinical Oncology. 38:1589-1589
1589 Background: We report our large cohort of pediatric cancer patients undergoing prospective agnostic germline sequencing. Our dataset is a significant addition to the 1,573 children reported to date who have undergone agnostic germline sequencing
Autor:
Megha Ranganathan, Jason A. Konner, Ozge Birsoy, Amanda Catchings, Michael F. Berger, Maria I. Carlo, Erin E. Salo-Mullen, Alicia Latham, Yelena Kemel, Kenneth Offit, Jaclyn F. Hechtman, Diana Mandelker, Elise Fiala, Zsofia K. Stadler, Michael Francis Walsh, Mark E. Robson, Jinru Shia, Amir Momeni-Boroujeni, Karen Cadoo, Robert A. Soslow
Publikováno v:
Journal of Clinical Oncology. 38:1527-1527
1527 Background: PMS2-associated Lynch syndrome (LS) may have a more modest phenotype than that associated with other mismatch repair (MMR) genes ( MLH1, MSH2, MSH6, EPCAM). Recent studies suggest limited extra-colonic cancers, and modified risk-redu
Autor:
Michael F. Berger, Yelena Kemel, Michael Francis Walsh, Maria I. Carlo, Karen Cadoo, Zsofia K. Stadler, Diana Mandelker, Ozge Birsoy, Kenneth Offit, Anna Maio, Mark E. Robson, Erin E. Salo-Mullen, David B. Solit, Alicia Latham, Margaret Sheehan, Alexander Drilon, Luis A. Diaz
Publikováno v:
Journal of Clinical Oncology. 38:1500-1500
1500 Background: Tumor mutational profiling for identification of somatic alterations for targeted treatment is increasingly being performed in advanced cancer patients (pts). We sought to assess the clinical utility of germline mutation profiling fo
Autor:
Yelena Kemel, Diana Mandelker, Mark E. Robson, Karen Cadoo, Michael Francis Walsh, Steven M. Lipkin, Zarina Shameer, Liying Zhang, Vignesh Ravichandran, Kenneth Offit, Zsofia K. Stadler, Vijai Joseph
Publikováno v:
Genetics in medicine : official journal of the American College of Medical Genetics
Cancer care professionals are confronted with interpreting results from multiplexed gene sequencing of patients at hereditary risk for cancer. Assessments for variant classification now require orthogonal data searches, requiring aggregation of multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65a4359e4709d3e26a66efe858d6e992
https://doi.org/10.1101/295865
https://doi.org/10.1101/295865